Cizzle Biotechnology Holdings plc (LON:CIZ) Executive Chairman Allan Syms joins DirectorsTalk to discuss the successful listing on to the Main Market of London Stock Exchange. Allan explains what the company does, how a blood test for the early detection of a majority of the different forms of lung cancer works, patents in place, how the proceeds will be utilised and how Allan views the outlook for the company.
Cizzle Biotechnology is a UK based developer of a blood test for the early detection of a majority of different forms of lung cancer.